$EFX

GAMBLE JOHN W JR sold $846K of EFX

GAMBLE JOHN W JR (EVP, CFO & COO) sold 4,500 shares of EQUIFAX INC (EFX) at $187.96 ($0.85M total) on 2026-09-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GAMBLE JOHN W JR
Published Sep 8, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EFX
Neutral
medium confidence
Mentioned
$EFX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EFXNeutralLow
01

Why it matters

The transaction provides fresh insider‑activity data but is unlikely to move the stock significantly.

02

Market read

Small insider sale with limited price impact; traders may watch for further insider activity.

03

What to watch

Possible upcoming earnings or strategic actions not yet disclosed.

Relevance 4/10Novelty 4/10Timing: filing Sep 8

Background

Equifax filed a Form 4 reporting an insider sale by its CFO under a 10b5‑1 plan.

Company-level read

Ticker impact

$EFXNeutralMedium confidence
Context

CFO John Gamble sold 4,500 Equifax shares for $845,820 on Sep 3, reducing his holding to 69,055 shares.

Expected impact

Potential slight downside in the near term.

Evidence & confidence

Sale size is modest relative to Equifax's market cap; senior insider but amount under $1M limits impact.

Market effects

Minimal effect on consumer‑credit sector dynamics.

Limited influence on US financial‑services market.

Low global relevance.

Counterpoint

The sale may be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Equifax Inc.

    US consumer credit reporting agency.

  • John Gamble

    Equifax EVP, CFO & COO.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EFXMed

Why Equifax (EFX) stock is down today

Equifax (EFX) shares fell 2.7% after RBC downgraded the stock to Sector Perform and raised its price target to $189. The downgrade cited valuation concerns and operating issues, including mortgage market weakness and regulatory risks. The stock later recovered slightly to $178.03, down 2.4%. Equifax's shares are down 16.8% year-to-date and 22.3% below their 52-week high.

$LMTHighAI 8/10

Lockheed Martin, Blackstone and P&G Beat Q3 Estimates as $14 Billion Deal Wave and $317.5 Million IPO Reshape US Markets

Lockheed Martin (LMT) reported Q3 EPS of $7.97, beating estimates, and raised its full-year revenue forecast to $80B-$82B. Blackstone (BX) beat EPS estimates with $1.32, and shares rose 8.4%. Procter & Gamble (PG) reported Q1 EPS of $2.00, beating estimates, with sales up 4%. Equifax (EFX) saw Q3 revenue rise 10%, with mortgage revenue up 15%, despite market weakness. Shares of all companies rose following earnings reports.

$EFXMed

Why Equifax (EFX) stock is trading up today

Equifax (EFX) stock rose 6.3% after Argus upgraded it to Buy with a $200 target, citing growth and a dividend increase. Q3 earnings beat estimates at $2.26 per share, with revenue up 9.6% to $1.69B. The stock is down 12.6% YTD and 20% below its 52-week high.